Back to search

National and Kapodistrian University of Athens

Η συνεργική δράση της πιβμεσιλλινάμης με το κλαβουλανικό οξύ έναντι στελεχών ουροπαθογόνων της κοινότητας με παραγωγή ESBL λακταμασών και η θέση της στη θεραπεία των ουρολοιμώξεων της κοινότητας

Abstract

dc:description

Background. Extended-spectrum b-lactamases (ESBLs) have emerged as an important mechanism of blactam resistance among community uropathogens. We characterized the ESBLs of a collection of Escherichia coli isolates recovered from outpatients with urinary tract infection during nationwide surveillance conducted from 2005 to 2006 in Greece, and evaluated the in vitro activity of mecillinam and mecillinam/clavulanate against them. Materials and methods. ESBLs were characterized with PCR and sequencing. In vitro interactions were evaluated with agar dilution with and without clavulanate (4 mg/L) using an inoculum of 104 or 106 cfu/spot as well as with time–kill methodology.Results. Among 48 ESBL producers, 47 (97.9%) were susceptible to mecillinam. CTX-M-type enzymes were produced by 87.2%, with CTX-M-3 being the most prevalent. SHV enzymes were found in 10.6%, VEB enzymes in 2.1%, TEM enzymes in 19.2% and OXA-type enzymes in 12.8%. Synergy with clavulanate was detected in 60.4% using the agar dilution method and in 43.8% using the time–kill methodology. An inoculum effect was detected in 64.6% of isolates, but this phenomenon was inverted and synergy was evidenced for 85.4% with clavulanate. When a high inoculum was used, 60.4% (29/48) were resistant to mecillinam, but 97.9% (47/48) were susceptible in the presence of clavulanate.Conclusions. CTX-M-type enzymes were the most prevalent among ESBL-producing E. coli uropathogens in Greece. Mecillinam may be useful in uncomplicated cystitis caused by ESBL producers with low MICs. The addition of the inhibitor could improve and extend the activity of mecillinam, even in the setting of infection with a high bacterial inoculum, and merits clinical evaluation.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Lampri, Niki
  • Λάμπρη, Νίκη

Subjects

dc:subject × 11

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41015

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Lampri, Niki; Λάμπρη, Νίκη. Η συνεργική δράση της πιβμεσιλλινάμης με το κλαβουλανικό οξύ έναντι στελεχών ουροπαθογόνων της κοινότητας με παραγωγή ESBL λακταμασών και η θέση της στη θεραπεία των ουρολοιμώξεων της κοινότητας. National and Kapodistrian University of Athens, 2012. http://hdl.handle.net/10442/hedi/41015